Revolution Medicines, Inc. (RVMD)

SEC filing

Revolution Medicines, Inc.

RVMD · CIK 1628171

4 · Oct 1, 2026 · Chief Development Officer Sandler Alan B. sold 6,309 shares at $202.14/share ($1.3M); exercised options for 12K shares

Chief Development Officer Sandler Alan B. sold 6,309 shares at $202.14/share ($1.3M); exercised options for 12K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).